XML 55 R41.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Current and Deferred Tax Provision

A summary of the Company’s current and deferred tax provision is as follows:

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

Current income tax expense:

 

 

 

 

 

 

Federal

 

$

-

 

 

$

-

 

State

 

 

10

 

 

 

13

 

Total current income tax expense

 

 

10

 

 

 

13

 

Deferred income tax expense (benefit):

 

 

 

 

 

 

Federal

 

 

1

 

 

 

1

 

State

 

 

(1

)

 

 

(1

)

Total deferred tax expense

 

 

 

 

 

 

Total expense from income taxes

 

$

10

 

 

$

13

 

Schedule of Reconciliation of the U.S. Federal Statutory Income Tax

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

Federal statutory income tax rate

 

 

21.0

%

 

 

21.0

%

State income taxes, net of federal benefits

 

 

1.4

%

 

 

(38.9

)%

Interest accretion expense

 

 

11.0

%

 

 

(186.9

)%

Change in valuation allowance

 

 

(20.0

)%

 

 

269.1

%

Mark to market warrant

 

 

0.5

%

 

 

(58.5

)%

Deferred true-up

 

 

(2.4

)%

 

 

0.2

%

Stock-based compensation

 

 

(0.0

)%

 

 

(8.2

)%

Impairment

 

 

(12.0

)%

 

 

5.3

%

Other permanent items

 

 

0.5

%

 

 

(3.1

)%

Effective income tax rate

 

 

(0.0

)%

 

 

(0.0

)%

Schedule of Net Deferred Tax Liabilities

Net deferred tax liabilities as of December 31, 2023 and 2022 consisted of the following:

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

109,544

 

 

$

102,723

 

Research and development tax credit carryforwards

 

 

5,674

 

 

 

5,674

 

Stock-based compensation expense

 

 

16,539

 

 

 

14,321

 

Startup costs

 

 

498

 

 

 

588

 

Intangible assets

 

 

3,442

 

 

 

3,905

 

Deferred revenue

 

 

1,441

 

 

 

1,135

 

Unicap

 

 

5

 

 

 

6

 

Imputed interest on contingent payments

 

 

110

 

 

 

5,654

 

Legal fee capitalization and amortization

 

 

1,171

 

 

 

1,342

 

Capitalized research and development

 

 

26,613

 

 

 

19,318

 

Other

 

 

4,751

 

 

 

3,121

 

Total deferred tax assets

 

 

169,788

 

 

 

157,787

 

Deferred tax liabilities:

 

 

 

 

 

 

In-process research and development

 

 

 

 

 

(27,271

)

Total deferred tax liabilities

 

 

 

 

 

(27,271

)

Valuation allowance

 

 

(169,797

)

 

 

(130,525

)

Net deferred tax liabilities

 

$

(9

)

 

$

(9

)

Schedule of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 

 

Unrecognized
Tax Benefits

 

Balance at December 31, 2021

 

$

1,270

 

Decrease related to current year tax provisions

 

 

(242

)

Balance at December 31, 2022

 

$

1,028

 

Decrease related to current year tax provisions

 

 

 

Balance at December 31, 2023

 

$

1,028